Skip to main content
. 2008 May 14;295(1):R123–R132. doi: 10.1152/ajpregu.00527.2007

Table 1.

Serum cytokine levels following 1V136 administration

Route
IL-6 (pg/ml)
TNF-α, pg/ml
Leptin, ng/ml

Vehicle
1V136, 150 nmol
LPS, 2 μg
Vehicle
1V136, 150 nmol
LPS, 2 μg
1V136, 150 nmol
LPS, 2 μg
IN IP IN IP IP IN IP IN IP IP IN IP
Time*
    0 h <10 <10 <10 <10 <10 < 20 < 20 < 20 < 20 < 20 1.34±0.24 1.32±0.18
    2 h <10 <10 1350±475 4576±338§ 6304±530§ 48±47 < 20 265±69 510±84§ 415±93 1.43±0.44 1.21±0.41
    6 h <10 <10 368±82 566±75 1172±327 < 20 < 20 23±4 33±6 39±8 2.57±0.50 2.47±0.58
    24 h 22±20 <10 115±56 74±29 372±118 < 20 < 20 < 20 < 20 < 20 1.10±0.30 1.32±0.22

Values are expressed as means ± SE. Mice were treated with vehicle intranasally (n = 6), 150 nmol in 1V136 (n = 8) or intraperitoneally (n = 8), or 2 μg ip LPS (from Escherichia coli 026:B6) (n = 8). Sera were collected 0, 2, 6, and 24 h after the treatment.

*

Hours after treatment.

P < 0.001 compared to 0 h by paired Student's t-test.

P < 0.05 compared to intranasal administration by unpaired Student's t-test.